EU Global Health Strategy

The Commission adopted on November 30 a new EU Global Health Strategy to improve global health security and deliver better health for all in a changing world. The Strategy positions global health as an essential pillar of EU external policy, a critical sector geopolitically and central to EU strategic autonomy.

Click here to read more.


View Project

Building Greater Resilience in Vaccine Manufacturing – McKinsey & Company

Preparing for the next pandemic is a priority for many national public-health leaders and requires them to lay the groundwork to mount an effective vaccine response.

Decision makers could set the stage for vaccine resilience by defining what their countries and regions need; assessing the local capacity to scale production of vaccine doses; identifying gaps and weaknesses in their national and regional vaccine value chains.

Read the full article here.

View Project

IC Member Afya Rekod to Simplify Access to Medical Records Through Strategic Collaboration  

GE Healthcare and Kenya-based start-up and IC member, Afya Rekod, have announced a strategic collaboration that seeks to transform care delivery through improved access to personal health data and medical records in Kenya, Nigeria, and South Africa. 

The partnership will give patients access to their health history and personal records, including radiological images, by enabling hospitals and diagnostic centers to host health records securely on one platform through a digital application. 

Click here for more information.

View Project

Experts discuss IP commercialisation, barriers to domestic innovation at 4th Annual IP Dialogue

Experts and Participants discussed support for intellectual property (IP) commercialization, challenges in fighting the global pandemic, barriers to domestic innovation, and the “next generation” of IP policy discussions in the digital economy at the 4th Annual IP Dialogue.

The US Chamber of Commerce’s Global Innovation Policy Center (GIPC) and US India Business Council, in partnership with the Federation of Indian Chambers of Commerce and Industry (FICCI), virtually convened government and industry leaders for the final session of its 4th annual IP Dialogue. Although the global pandemic continues to affect millions, this year’s dialogue proved to be incredibly impactful, with IP playing such a key role in efforts to study and combat the ongoing global pandemic.

Read the full story.

View Project

University to help health practitioners find innovative solutions to healthcare challenges

The growing challenges on healthcare systems around the world has inspired researchers at the University of Bath to devise an online course to help healthcare practitioners spot opportunities for innovation in their organisations, and put ideas into practise.

The free online course, known as a MOOC (Massive Open Online Course) takes four weeks to complete and is devised by the School of Management’s Centre for Healthcare Innovation and Improvement (CHI²), along with the West of England Academic Health Science Network (AHSN).

Read the full story.

View Project

What South Korea’s vaccine industry success teaches us about global trade policy

Jennifer Brant of the Innovation Council co-authored an article with Godfrey Firth for the World Economic Forum that uses the example of South Korea to show that tariff, trade facilitation and regulatory harmonisation measures can facilitate the global response to health crises such as COVID-19.

Read the full story.

View Project

Capacity Building for Vaccine Manufacturing Across Developing Countries: The Way Forward

Innovation Council member Techinvention has published an article on capacity building for vaccine manufacturing. The authors of the paper show that challenges in the life cycle of vaccine production include process development, lead time, intellectual property, and local vaccine production. A robust and stable manufacturing process and constant raw material supplies over decades is critical. In a continuously evolving vaccine landscape, the need of the hour for developing nations is to manufacture their own vaccines besides having supply security, control over production scheduling and sustainability, control of costs, socio-economic development, and rapid response to local epidemics. There is a need for capacity building of workforce development, technology transfer, and financial support. Technology transfer has improved vaccine access and reduced prices of vaccines. Capacity building for the manufacturing of vaccines in developing countries has always been an area of paramount importance and more so in a pandemic situation. 

Read the full story.

View Project

Webinar on BioManufacturing: Expanding Production Capacity in Emerging Regions

The Innovation Council and Bobab organised a discussion on expanding BioManufacturing production capacity in emerging regions. Biologics, a category of pharmaceuticals which includes products such as vaccines and monoclonal antibody treatments, are quickly becoming among the most important medical products in the world. By combining enabling government policies and technology transfer between innovators and their global partners, it will be possible to improve availability of biologics, increase health security, and enhance scientific and industrial capacity in developing countries.

Watch the webinar.

Information about speaker Anissa Boumlic is available here.

Information about speaker Mark Schultz is available here.

Information about speaker Simon Agwale is available here.

Information about AVMI is available here.

For more information on this discussion, click here to see the transcript.

View Project

Americans don’t have equal access to mental healthcare but technology is making it more democratic

One of the oldest, yet still unresolved issues plaguing the US health system is the unequal distribution of healthcare. This past August, a new study by JAMA revealed the ongoing disparity in healthcare spending by race. In particular, mental healthcare remains highly inaccessible across the board, but particularly for certain groups. Patients are screened for mental health in less than 5% of primary care visits, and Black people are half as likely to be examined than white people. And the elderly are also half as likely to be screened than middle-aged patients. However, novel health technologies are allowing us to move into a new era of equality and improved access to healthcare for everyone, eliminating the barriers between people and healthcare, by putting the patient at the center of care versus the provider.

Read the full story

View Project